- Home
- Labeler Index
- Eli Lilly Italia Spa
- 54568-766
- NDC Crossover: 54568-766 Insulin Glargine
NDC Crossover 54568-766 Insulin Glargine
View and Compare Similar Products, Alternatives & Options
NDC Crossover of Similar Products Matching Insulin Glargine
Explore similar products and medications to NDC 54568-766 Insulin Glargine drug for further processing with other products crossover matching the same product name (Insulin Glargine) or generic name (Insulin Glargine), and the same administration route () or dosage form (injection, solution). This comprehensive list of related drugs for easy comparison is ideal for healthcare professionals & patients seeking alternatives.
NDC | Proprietary Name | Non-Proprietary Name | Dosage Form | Route Name | Company Name | Product Type |
---|---|---|---|---|---|---|
0002-7715 | Basaglar KwikPen | Insulin Glargine | Injection, Solution | Subcutaneous | Eli Lilly And Company | Human Prescription Drug |
0002-8214 | Basaglar Tempo Pen | Insulin Glargine | Injection, Solution | Subcutaneous | Eli Lilly And Company | Human Prescription Drug |
0024-5869 | Toujeo | Insulin Glargine | Injection, Solution | Subcutaneous | Sanofi-aventis U.s. Llc | Human Prescription Drug |
0024-5871 | Toujeo Max | Insulin Glargine | Injection, Solution | Subcutaneous | Sanofi-aventis U.s. Llc | Human Prescription Drug |
0088-2219 | Lantus Solostar | Insulin Glargine | Injection, Solution | Subcutaneous | Sanofi-aventis U.s. Llc | Human Prescription Drug |
0088-2220 | Lantus | Insulin Glargine | Injection, Solution | Subcutaneous | Sanofi-aventis U.s. Llc | Human Prescription Drug |
0088-5020 | Lantus Solostar | Insulin Glargine | Injection, Solution | Subcutaneous | Sanofi-aventis U.s. Llc | Human Prescription Drug |
0088-5021 | Lantus | Insulin Glargine | Injection, Solution | Subcutaneous | Sanofi-aventis U.s. Llc | Human Prescription Drug |
0955-1728 | Insulin Glargine Solostar | Insulin Glargine | Injection, Solution | Subcutaneous | Winthrop U.s. | Human Prescription Drug |
0955-1729 | Insulin Glargine | Insulin Glargine | Injection, Solution | Subcutaneous | Winthrop U.s. | Human Prescription Drug |
0955-2900 | Insulin Glargine U-300 Max | Insulin Glargine | Injection, Solution | Subcutaneous | Winthrop U.s, A Business Of Sanofi-aventis U.s. Llc | Human Prescription Drug |
0955-3900 | Insulin Glargine U-300 | Insulin Glargine | Injection, Solution | Subcutaneous | Winthrop U.s, A Business Of Sanofi-aventis U.s. Llc | Human Prescription Drug |
50090-0876 | Lantus | Insulin Glargine | Injection, Solution | Subcutaneous | A-s Medication Solutions | Human Prescription Drug |
50090-1398 | Lantus Solostar | Insulin Glargine | Injection, Solution | Subcutaneous | A-s Medication Solutions | Human Prescription Drug |
50090-2193 | Toujeo | Insulin Glargine | Injection, Solution | Subcutaneous | A-s Medication Solutions | Human Prescription Drug |
50090-4068 | Lantus Solostar | Insulin Glargine | Injection, Solution | Subcutaneous | A-s Medication Solutions | Human Prescription Drug |
50090-4177 | Toujeo Max | Insulin Glargine | Injection, Solution | Subcutaneous | A-s Medication Solutions | Human Prescription Drug |
50090-6178 | Insulin Glargine Solostar | Insulin Glargine | Injection, Solution | Subcutaneous | A-s Medication Solutions | Human Prescription Drug |
50090-6184 | Insulin Glargine | Insulin Glargine | Injection, Solution | Subcutaneous | A-s Medication Solutions | Human Prescription Drug |